Norges Bank’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,574
Closed -$3.72M 1275
2025
Q4
$3.72M Buy
+30,574
New +$3.84M ﹤0.01% 1409
2025
Q3
Sell
-40,274
Closed -$5.4M 1424
2025
Q2
$5.4M Hold
40,274
﹤0.01% 1323
2025
Q1
$2.71M Sell
40,274
-326,387
-89% -$22.4M ﹤0.01% 1471
2024
Q4
$22.9M Buy
366,661
+8,581
+2% +$799K ﹤0.01% 1210
2024
Q3
$56.2M Buy
358,080
+88,206
+33% +$13.6M 0.01% 920
2024
Q2
$40.6M Buy
+269,874
New +$32.4M 0.01% 988
2023
Q2
Sell
-129,500
Closed -$9.81M 2112
2023
Q1
$9.81M Buy
+129,500
New +$8.96M ﹤0.01% 1591

Other funds holding TMDX

Norges Bank's TMDX Position: Q1 2026 in Review

Norges Bank sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 30,574 shares — an estimated $3.72M sold.

Norges Bank first reported a position in TMDX in Q1 2023 and held it in 7 quarters. The position peaked at $56.2M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Norges Bank reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 30,574 Transmedics shares in Q1 2026, an estimated $3.72M.
  • Norges Bank first reported a position in Transmedics in Q1 2023 and held it in 7 quarters.
  • Norges Bank's Transmedics position peaked at $56.2M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.